Antiretroviral therapy in Indian setting: when & what to start with, when & what to switch to?
With the rapid scale-up of antiretroviral therapy, there is a dramatic decline in HIV related morbidity and mortality in both developed and developing countries. Several new safe antiretroviral, and newer class of drugs and monitoring assays are developed recently. As a result the treatment guideline for the management of HIV disease continue to change. This review focuses on evolving science on Indian policy--antiretroviral therapy initiation, which drugs to start with, when to change the initial regimen and what to change.
YRG CARE Medical Centre, Voluntary Health Services, Chennai, India. kumarasamy@yrgcare.org
N
N
Kumarasamy
Atul
A
Patel
Sanjay
S
Pujari
D019380:Anti-HIV Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active / Q000379:methods*; D015658:HIV Infections / Q000188:drug therapy* / Q000453:epidemiology*; D006801:Humans; D007194:India / Q000453:epidemiology
D019380:Anti-HIV Agents